ARL8BCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。ARL8B遺伝子サイレンサーは、ARL8B CRISPR/Cas9ノックアウトプラスミドとARL8BDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のARL8BCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
ARL8B CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ARL8A CRISPR/Cas9 KOプラスミド (h) | sc-405530 | h | Gene Knockout | GFP | 0 | ||
ARL8A HDRプラスミド (h) | sc-405530-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ARL8A Double Nickaseプラスミド (h) | sc-405530-NIC | h | Gene Knockout | Puromycin | 0 | ||
ARL8A Double Nickaseプラスミド (h2) | sc-405530-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ARL8A CRISPR/Cas9 KOプラスミド (m) | sc-427153 | m | Gene Knockout | GFP | 0 | ||
ARL8A HDRプラスミド (m) | sc-427153-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ARL8A Double Nickaseプラスミド (m) | sc-427153-NIC | m | Gene Knockout | Puromycin | 0 | ||
ARL8A Double Nickaseプラスミド (m2) | sc-427153-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
ARL8B CRISPR/Cas9 KOプラスミド (h) | sc-405529 | h | Gene Knockout | GFP | 0 | ||
ARL8B HDRプラスミド (h) | sc-405529-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
ARL8B Double Nickaseプラスミド (h) | sc-405529-NIC | h | Gene Knockout | Puromycin | 0 | ||
ARL8B Double Nickaseプラスミド (h2) | sc-405529-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
ARL8B CRISPR/Cas9 KOプラスミド (m) | sc-426422 | m | Gene Knockout | GFP | 0 | ||
ARL8B HDRプラスミド (m) | sc-426422-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
ARL8B Double Nickaseプラスミド (m) | sc-426422-NIC | m | Gene Knockout | Puromycin | 0 | ||
ARL8B Double Nickaseプラスミド (m2) | sc-426422-NIC-2 | m | Gene Knockout | Puromycin | 0 |
ARL8B CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
ARL8A CRISPR Activationプラスミド (h) | sc-405530-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A CRISPR Activationプラスミド (h2) | sc-405530-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A Lentiviral Activation Particles (h) | sc-405530-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A Lentiviral Activation Particles (h2) | sc-405530-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A CRISPR Activationプラスミド (m) | sc-427153-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A CRISPR Activationプラスミド (m2) | sc-427153-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A Lentiviral Activation Particles (m) | sc-427153-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8A Lentiviral Activation Particles (m2) | sc-427153-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B CRISPR Activationプラスミド (h) | sc-405529-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B CRISPR Activationプラスミド (h2) | sc-405529-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B Lentiviral Activation Particles (h) | sc-405529-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B Lentiviral Activation Particles (h2) | sc-405529-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B CRISPR Activationプラスミド (m) | sc-426422-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B CRISPR Activationプラスミド (m2) | sc-426422-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B Lentiviral Activation Particles (m) | sc-426422-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
ARL8B Lentiviral Activation Particles (m2) | sc-426422-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |